Sept 30 (Reuters) - Dova Pharmaceuticals Inc  DOVA.O :
    * DOVA PHARMACEUTICALS TO BE ACQUIRED BY SWEDISH ORPHAN
BIOVITRUM
AB (SOBI)
    * CONSIDERATION OF UP TO $29.00 PER SHARE INCLUDES $27.50
PER
SHARE IN UPFRONT CASH AND AN ADDITIONAL $1.50 PER SHARE
    * TOTAL POTENTIAL CONSIDERATION OF UP TO $915 MILLION ON A
FULLY
DILUTED BASIS
    * TRANSACTION EXPECTED TO BE COMPLETED IN Q4 2019
    * TRANSACTION WAS UNANIMOUSLY APPROVED BY BOARDS OF
DIRECTORS OF
BOTH COMPANIES

Source text for Eikon:  ID:nGNX4BRnM0 
Further company coverage:  DOVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))